Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Veru (VERU) announced positive topline results from the Phase 2b QUALITY clinical study. The Phase 2b QUALITY clinical study was placebo-controlled dose-finding study to evaluate the safety and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk stock gains as its subcutaneous investigational candidate, amycretin, achieves superior weight loss compared to ...

Novo Nordisk A/S (NYSE:NVO) released topline results from a phase 1b/2a trial with amycretin intended for once-weekly ...

Staci Rice lost 64 pounds on a compounded form of the weight loss drug semaglutide. It was expensive so she tried to maintain her weight loss without the medication, and gained 26 pounds.

"Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket ... [+] medication costs increase," writes Pipes. Just three days before President Biden left office ...

Lizzo is feeling "Good as Hell" as she celebrates a major milestone in her weight loss journey. The "About Damn Time" singer, 36, shared Saturday on Instagram that she has "reached my weight ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the press and the medical community for its ability to trigger profound weight loss.

With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned to the trickier task of finding a way to lose fat while retaining muscle.